Spero Therapeutics (SPRO) Total Debt (2016 - 2026)
Spero Therapeutics (SPRO) reported Total Debt of $91000.0 for Q1 2026, little changed quarter-over-quarter from $91000.0 in Q4 2025.
Spero Therapeutics (SPRO) Total Debt (2016 - 2026) Analysis & Trends
Spero Therapeutics has reported Total Debt for 11 years, with the latest figure at $91000.0 in Q1 2026.
- For the quarter ending Q1 2026, Total Debt changed N/A year-over-year to $91000.0; the trailing twelve-month figure through Mar 2026 stood at $91000.0 (changed N/A YoY), and the FY2025 full-year result was $91000.0, changed N/A from the prior year.
- Total Debt for Q1 2026 stood at $91000.0, roughly flat from $91000.0 in the prior quarter.
- The five-year high for Total Debt was $1.1 million in Q1 2022, with the low at $13000.0 in Q3 2024.
- Historically, Total Debt has averaged $174076.9 across 5 years, with a median of $87000.0 in 2023.
- Annual changes were most pronounced in 2022 — Total Debt jumped 568.45% — and 2023, when it slumped 92.43%.
- Spero Therapeutics' Total Debt stood at $96000.0 in 2022, then slipped by 9.38% to $87000.0 in 2023, then plunged by 85.06% to $13000.0 in 2024, then surged by 600.0% to $91000.0 in 2025, then changed by 0.0% to $91000.0 in 2026.
- The last three Total Debt figures came in at $91000.0 (Q1 2026), $91000.0 (Q4 2025), and $13000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | 91,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Dec 31, 2023 | 87,000.00 |
| Sep 30, 2023 | 62,000.00 |
| Jun 30, 2023 | 72,000.00 |
| Mar 31, 2023 | 85,000.00 |
| Dec 31, 2022 | 96,000.00 |
| Sep 30, 2022 | 248,000.00 |
| Jun 30, 2022 | 232,000.00 |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 138,000.00 |
| Sep 30, 2021 | 148,000.00 |
| Jun 30, 2021 | 158,000.00 |
| Mar 31, 2021 | 168,000.00 |
| Dec 31, 2020 | 177,000.00 |
| Sep 30, 2020 | 186,000.00 |
| Jun 30, 2020 | 196,000.00 |